Small Molecule Drug Discovery Market to Grow at a CAGR of 9.5%

1
Small Molecule Drug Discovery Market 
Small Molecule Drug Discovery Market Forecast to
2027 - COVID-19 Impact and Global Analysis by
Therapeutic Area (Oncology, Central Nervous
System, Cardiovascular, Respiratory, Orthopedics,
Immunology, Rare Diseases, and Other Therapeutic
Areas) Process/Phase (Target Discovery, Target
Validation, Lead Generation and Refinement, and
Preclinical Development) and Geography
2
Current and future Market Scenario
Small Molecule Drug Discovery Market 
According to the latest study on "Small Molecule
Drug Discovery Market Forecast to 2027 COVID-19
Impact and Global Analysis by Therapeutic Area
and Process/Phase", the global small molecule
drug discovery market was valued at US 24,976.14
million in 2019 and is projected to reach US
50,823.06 million by 2027 it is expected to grow
at a CAGR of 9.5 during 20202027. The report
highlights trends prevailing in the global small
molecule drug discovery market and the factors
driving market along with those that act as
hindrances.
3
Market Segments
Small Molecule Drug Discovery Market   
By Therapeutic Area Oncology, Central Nervous
System, Cardiovascular, Respiratory, Orthopedics,
Immunology, Rare Diseases,
By Process/Phase Target Discovery, Target
Validation, Lead Generation and
Refinement, Preclinical Development
4
Leading Players
Small Molecule Drug Discovery Market  
Company Profiles in Small Molecule Drug
Discovery Market are Johnson and Johnson
Services, Inc. Teva Pharmaceutical Industries
Ltd Boehringer Ingelheim International
GmbH Allergan Plc. Pfizer Inc. Bristol-Myers
Squibb Company MERCK KGaA GlaxoSmithKline
plc. AstraZeneca Gilead Sciences, Inc.
5
Small Molecule Drug Discovery Market  
Access Full Research Report at
https//www.theinsightpartners.com/sample/TIPRE000
04774/
Thank You!

• Thank You!